FDA Cleared
New Device
Pathway: 510K
Foster Plus-22L (SNK/CE-F22)
Applicant:
Zhejiang Fomos Medical Technology Co., Ltd.
Statutory Profile
Legal Standard:
Substantial Equivalence (SE) to predicate (21 CFR 807)
Product Code:
FLE
Review Panel:
General Hospital
21 CFR Regulation:
8
Review Velocity Metrics
Date Received:
2026-02-03
Decision Date:
2026-10-30
Total Review Duration:
269 calendar days (269 days)
Official FDA Research Backlinks
Direct links to primary official records hosted by the U.S. Food and Drug Administration CDRH databases:
Identified Contacts & Correspondents
My G Tran
Role: SUBMITTER_CONTACT
Notice a discrepancy or outdated information on this record?
Report to support@fdacleared.org